What Planatome Technology does

Planatome Technology is a Phoenix, Arizona-based medical device company founded in 2017 that applies chemical mechanical planarization (CMP) — a precision finishing process adapted from semiconductor chip manufacturing — to produce nano-polished surgical cutting instruments. The company's core product line is disposable surgical scalpel blades (#10, #11, #15, #15c) with surface roughness of 5-20nm, approximately 1,000x smoother than conventional ground blades (Ra 5,000-50,000nm), which the company claims produces cleaner incisions, faster healing, less scarring, and 5x-15x greater durability. The technology platform extends to a mail-in sharpening and refinishing service for reusable instruments (scissors, rongeurs, curettes, osteotomes priced at $21-$48 per instrument) and to OEM technology licensing agreements with medical device manufacturers targeting handheld surgical instruments, energy-based/electrosurgical components, neuro/microsurgical instruments, and robotic/laparoscopic end-effectors.

The company was originally a division of Entrepix, Inc. and completed its spinout in October 2023, simultaneously closing a $5M Series A equity round plus $1M convertible venture debt (total $6M). The go-to-market is a hybrid of direct sales to surgeons and hospitals (supported by clinical trials, surgeon testimonials, and a sample kit program), sales-led hospital adoption, event-driven presence at surgical training programs such as the Duke Flap Course 2025, and OEM licensing. Planatome's blades are FDA-approved (21 CFR Part 820) for the US market and approved in South Korea, with adoption across multiple US hospitals and surgical centers. The leadership team combines semiconductor industry veterans (Motorola, Intel, SpeedFam-IPEC, Cabot Microelectronics/Entegris) with medical device executives from Johnson & Johnson/Ethicon, Merz Pharma, Ulthera, and GT Medical Technologies. In February 2024, the company announced a new manufacturing facility in the greater Phoenix area and a plan to more than double its workforce over the next five years.

Name

Planatome Technology

Legal name

Planatome, LLC

Website

https://planatome.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Planatome Technology is a Phoenix-based medical device company that applies semiconductor-derived chemical mechanical planarization to produce nano-polished surgical blades and cutting instruments with surfaces roughly 1,000x smoother than conventional blades, selling direct to surgeons and hospitals and licensing its technology to medical device OEMs.

Ownership category

akta.pro rank

Product category

Surgical Instruments

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (33911)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

akta.pro secondary industries

Chemical Mechanical Planarization (CMP) Equipment (HDAHAEAF), Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC), Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

Keywords

• Nano-polished surgical blades
• Chemical mechanical planarization
• Surgical instrument sharpening
• Medical device manufacturing
• OEM technology licensing

Headquarters

HQ city

Phoenix

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Surgical Blade Sales: Planatome sells nano-polished disposable surgical scalpel blades (#10, #11, #15, #15c) directly to surgeons, hospitals, and surgical centers. Blades are sterile, single-patient, one-time use. The company also sells blades to OEM partners for integration into their product lines.
2. Instrument Sharpening Services: Planatome provides professional sharpening and nano-polishing services for reusable surgical instruments including scissors (general, supercut, carbide, micro & delicate), rongeurs, curettes, and osteotomes. Instruments are shipped to the facility, serviced within 1 week turnaround, with recurring service available on a case-by-case basis.
3. Technology Licensing (OEM): Planatome licenses its proprietary CMP/nano-polishing technology to medical device manufacturers (OEM partners), enabling them to integrate nano-polished cutting surfaces into their own branded products. Agreements are flexible, tailored to each partner, and may include technology transfer, training, ongoing technical support, and co-development.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

Planatome manufactures and sells disposable nano-polished surgical scalpel blades (#10, #11, #15, #15c) that use chemical mechanical planarization (CMP) technology to deliver near molecular-perfect cutting edges with surface roughness of Ra 5–20 nm. The company also provides a surgical instrument sharpening and nano-polishing service for reusable instruments such as scissors, rongeurs, curettes, and osteotomes, and licenses its proprietary CMP technology to OEM medical device manufacturers for integration into their own branded surgical cutting instruments.

Product overview

Planatome Technology is a medical device company that offers a platform of nano-polishing technology for surgical cutting instruments. The core offering consists of Planatome nano-polished surgical blades (#10, #11, #15, #15c), which are finished using proprietary chemical mechanical planarization (CMP) technology adapted from semiconductor manufacturing. The company also provides instrument sharpening/nano-polishing services for reusable surgical tools (scissors, rongeurs, curettes, osteotomes) and licenses its technology to OEM partners for integration into their surgical instrument product lines.

Differentiator

Problem solved

Functional benefit

Products and services

• Planatome Nano-Polished Surgical Scalpel Blades Disposable, sterile, single-patient surgical scalpel blades (#10, #11, #15, #15c) finished using chemical mechanical planarization (CMP) to deliver near molecular-perfect cutting edges with surface roughness of Ra 5–20 nm, sold to surgeons, hospitals, and surgical centers in the U.S. and South Korea.
• Surgical Instrument Sharpening and Nano-Polishing Service Mail-in service that restores reusable surgical instruments — including general scissors, supercut scissors, tungsten carbide scissors, micro and delicate scissors, rongeurs, curettes, and osteotomes — to a mirror-smooth nano-polished finish via CMP, with approximately one-week turnaround and recurring service available.
• OEM Technology Licensing Program Multi-year technology licensing arrangement that enables medical device manufacturers to integrate Planatome's proprietary CMP nano-polishing into their own branded surgical instruments, with flexible terms that may include technology transfer, training, ongoing technical support, and co-development.

Quantifiable outcome

• 90% wound closure within 72 hours vs. 10% with standard scalpels
• +6 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Arizona Commerce AuthoritycoreStrategic or Co-development PartnerThe Arizona Commerce Authority (ACA) supports Planatome's growth in Arizona through the Arizona Manufacturing Extension Partnership (AZ MEP), which provides resources including workforce solutions, supply chain optimization, and business development support. ACA also facilitated the announcement of Planatome's new manufacturing facility in the greater Phoenix area.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Becton Dickinson (BD): BD is a global medical technology giant with a large surgical and medical instruments portfolio, including surgical blades (Persona Plus) and a wide range of OR consumables. As a broad incumbent, BD competes on scale, GPO contracts, and distribution reach — the structural advantages Planatome must overcome.
• Medline Industries: Medline is the largest privately held medical device manufacturer and distributor in the US, offering a broad portfolio of surgical instruments, blades, and OR supplies. It dominates the GPO/distributor channel that Planatome needs to penetrate for hospital adoption.
• Integra LifeSciences: Integra LifeSciences is a large medical device company with a strong portfolio in surgical instruments, neurosurgery, and ENT. It serves many of the same specialties (plastic, neuro, microsurgery) that Planatome targets and could be both a competitor and a potential OEM licensing partner.
• Stryker: Stryker is a major medical device company with a strong surgical instruments, robotics (Mako), and energy-based device portfolio. It overlaps with Planatome's OEM licensing targets in surgical robotics, electrosurgical devices, and laparoscopic end-effectors, and could be a potential acquirer.
• Conmed: Conmed manufactures electrosurgical devices, surgical instruments, and OR consumables. It directly overlaps with Planatome's OEM licensing focus on energy-based/electrosurgical components and serves the same hospital and surgical center channels.

Direct peers

• Hu-Friedy (now part of Cantel Medical / Steris): Hu-Friedy is a leading manufacturer of dental and surgical instruments, including scalpels, scissors, and reusable surgical tools. Its instrument sharpening and refurbishment services overlap directly with Planatome's mail-in instrument sharpening business.
• Surgical Specialties (DemeTECH): Surgical Specialties (now part of DemeTECH) manufactures surgical blades, sutures, and microsurgical instruments. It is a direct competitor in specialty surgical blades, particularly for ophthalmic and plastic surgery applications where Planatome's KOLs practice.
• Aspen Surgical (Baxter): Aspen Surgical, now part of Hillrom/Baxter, manufactures a wide range of surgical consumables including scalpels, blades, and disposable instruments. It is a direct competitor in the US hospital blade market and competes for the same hospital procurement contracts Planatome is targeting.
• Swann-Morton: Swann-Morton is one of the world's largest manufacturers of surgical scalpels and blades, headquartered in the UK with a global footprint. It is the most direct competitor to Planatome in the surgical blade category and represents the entrenched incumbent Planatome must displace.

Others

• Entrepix (Amtech Systems): Entrepix was Planatome's parent company and is where the CMP technology was originally developed; it is now part of Amtech Systems and serves the semiconductor CMP equipment market. It represents the technology lineage and a potential supply chain / IP relationship that could affect Planatome's manufacturing economics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/planatome
• Xx.com/planatome
• Facebookfacebook.com/profile.php

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Planatome Technology